Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4886)
All Articles published online
|
Jun 21, 2009 (publication date) through Nov 30, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tarantino G, Di Minno MND, Capone D. Drug-induced liver injury: Is it somehow foreseeable? World J Gastroenterol 2009; 15(23): 2817-2833 [PMID: 19533803 DOI: 10.3748/wjg.15.2817] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v15/i23/2817.htm |
| Number | Citing Articles |
| 1 |
Chenglin Han, Zilong Wang, Yingkun Xu, Shuxiao Chen, Yuqing Han, Lin Li, Muwen Wang, Xunbo Jin, Hannes Stockinger. Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1269624
|
| 2 |
Haoming Zhou, Yu Sun, Qingyuan Wang, Zhi Li, Weizhe Zhong, Xuehao Wang, Xinzheng Dai, Lianbao Kong. N-acetylcysteine alleviates liver injury by suppressing macrophage-mediated inflammatory response post microwave ablation. International Immunopharmacology 2020; 85: 106580 doi: 10.1016/j.intimp.2020.106580
|
| 3 |
Mauro Cataldi, Vincenzo Citro, Chiara Resnati, Federica Manco, Giovanni Tarantino. New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants. Advances in Therapy 2021; 38(5): 2094 doi: 10.1007/s12325-021-01669-y
|
| 4 |
Helmut Ostermann, Carlos Solano, Isidro Jarque, Carolina Garcia-Vidal, Xin Gao, Jon Andoni Barrueta, Marina De Salas-Cansado, Jennifer Stephens, Mei Xue, Bertram Weber, Claudie Charbonneau. Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain. BMC Pharmacology and Toxicology 2014; 15(1) doi: 10.1186/2050-6511-15-52
|
| 5 |
Jiacai Hu, Zhijie Yang, Hao Wu, Daochun Wang. Rhein attenuates renal inflammatory injury of uric acid nephropathy via lincRNA-Cox2/miR-150-5p/STAT1 axis. International Immunopharmacology 2020; 85: 106620 doi: 10.1016/j.intimp.2020.106620
|
| 6 |
Rolf Teschke, Gaby Danan. Idiosyncratic Drug Induced Liver Injury, Cytochrome P450, Metabolic Risk Factors and Lipophilicity: Highlights and Controversies. International Journal of Molecular Sciences 2021; 22(7): 3441 doi: 10.3390/ijms22073441
|
| 7 |
Ignacio Bernabeu, Mónica Marazuela, Tomás Lucas, Lourdes Loidi, Cristina Alvarez-Escolá, Manuel Luque-Ramírez, Eva Fernandez-Rodriguez, Amalia-Elisa Paniagua, Celsa Quinteiro, Felipe F. Casanueva. Pegvisomant-Induced Liver Injury Is Related to the UGT1A1*28 Polymorphism of Gilbert’s Syndrome. The Journal of Clinical Endocrinology & Metabolism 2010; 95(5): 2147 doi: 10.1210/jc.2009-2547
|
| 8 |
Saravanakumar Selvaraj, Jung-Hwa Oh, Reinhard Spanel, Florian Länger, Hyoung-Yun Han, Eun-Hee Lee, Seokjoo Yoon, Jürgen Borlak. The pathogenesis of diclofenac induced immunoallergic hepatitis in a canine model of liver injury. Oncotarget 2017; 8(64): 107763 doi: 10.18632/oncotarget.21201
|
| 9 |
Pragyan Acharya, Komal Chouhan, Sabine Weiskirchen, Ralf Weiskirchen. Cellular Mechanisms of Liver Fibrosis. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.671640
|
| 10 |
José Francisco Rocha, Ana Santos, Amílcar Falcão, Nelson Lopes, Teresa Nunes, Roberto Pinto, Patrício Soares-da-Silva. Effect of moderate liver impairment on the pharmacokinetics of opicapone. European Journal of Clinical Pharmacology 2014; 70(3): 279 doi: 10.1007/s00228-013-1602-9
|
| 11 |
JÉSSICA B. DE JESUS, RAISSA A. DA CONCEIÇÃO, THAYNÁ R. MACHADO, MARIA L.C. BARBOSA, THAISA F.S. DOMINGOS, LUCIO M. CABRAL, CARLOS R. RODRIGUES, BÁRBARA ABRAHIM-VIEIRA, ALESSANDRA M.T. DE SOUZA. Toxicological assessment of SGLT2 inhibitors metabolites using in silico approach. Anais da Academia Brasileira de Ciências 2022; 94(suppl 3) doi: 10.1590/0001-3765202220211287
|
| 12 |
M. Sistanizad, G. M. Peterson. Drug-induced liver injury in the Australian setting. Journal of Clinical Pharmacy and Therapeutics 2013; 38(2): 115 doi: 10.1111/jcpt.12039
|
| 13 |
Misagh Alipour, Caroline Buonocore, Abdelwahab Omri, Mary Szabo, Kresimir Pucaj, Zacharias E. Suntres. Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity. Journal of Drug Targeting 2013; 21(5): 466 doi: 10.3109/1061186X.2013.765443
|
| 14 |
Per-Jostein Samuelsen, Lars Slørdal, Ulla Dorte Mathisen, Anne Elise Eggen. Analgesic use in a Norwegian general population: change over time and high-risk use - The Tromsø Study. BMC Pharmacology and Toxicology 2015; 16(1) doi: 10.1186/s40360-015-0016-y
|
| 15 |
Jie Zhang, Utkarsh Doshi, Ayako Suzuki, Ching-Wei Chang, Jürgen Borlak, Albert P. Li, Weida Tong. Evaluation of multiple mechanism-based toxicity endpoints in primary cultured human hepatocytes for the identification of drugs with clinical hepatotoxicity: Results from 152 marketed drugs with known liver injury profiles. Chemico-Biological Interactions 2016; 255: 3 doi: 10.1016/j.cbi.2015.11.008
|
| 16 |
Xia Luo, Xiaojing Wang, Shaowei Huang, Bo Xu, Shuang Luo, Yanyang Li, Qing Wang, Yanping Chen, Xiangliang Deng, Lingyun Liu, Lian Zhou. Paeoniflorin ameliorates experimental colitis by inhibiting gram-positive bacteria-dependent MDP-NOD2 pathway. International Immunopharmacology 2021; 90: 107224 doi: 10.1016/j.intimp.2020.107224
|
| 17 |
Eman M. Radwan, Eman Abo-Elabass, Atef E. Abd El-Baky, Hussah Abdullah Alshwyeh, Riyad A. Almaimani, Ghassan Almaimani, Ibrahim Abdel Aziz Ibrahim, Abdulaziz Albogami, Mariusz Jaremko, Samar Z. Alshawwa, Essa M. Saied. Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma. Frontiers in Chemistry 2023; 11 doi: 10.3389/fchem.2023.1231030
|
| 18 |
Xiaoyan Li, Yujie Liu, Erhong Zhang, Qiong He, Yong-Bo Tang. Liver Transplantation in Antituberculosis Drugs-Induced Fulminant Hepatic Failure. Medicine 2015; 94(49): e1665 doi: 10.1097/MD.0000000000001665
|
| 19 |
Lei Cao, Xi-Bing Quan, Wen-Jiao Zeng, Xiao-Ou Yang, Ming-Jie Wang. Mechanism of Hepatocyte Apoptosis. Journal of Cell Death 2016; 9: JCD.S39824 doi: 10.4137/JCD.S39824
|
| 20 |
Rasha E. Mostafa, Abeer A.A. Salama, Rehab F. Abdel-Rahman, Hanan A. Ogaly. Hepato- and neuro-protective influences of biopropolis on thioacetamide-induced acute hepatic encephalopathy in rats. Canadian Journal of Physiology and Pharmacology 2017; 95(5): 539 doi: 10.1139/cjpp-2016-0433
|
| 21 |
Gordon Liss, Sushil Rattan, James H Lewis. Predicting and preventing acute drug-induced liver injury: what's new in 2010?. Expert Opinion on Drug Metabolism & Toxicology 2010; 6(9): 1047 doi: 10.1517/17425255.2010.503706
|
| 22 |
Julian Krauskopf, Marcha Verheijen, Jos C Kleinjans, Theo M de Kok, Florian Caiment. Development and Regulatory Application of Microrna Biomarkers. Biomarkers in Medicine 2015; 9(11): 1137 doi: 10.2217/bmm.15.50
|
| 23 |
Raghad D. Alamri, Mazen A. Elmeligy, Ghadeer A. Albalawi, Sarah M. Alquayr, Samaher S. Alsubhi, Sabah H. El-Ghaiesh. Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review. International Immunopharmacology 2021; 93: 107398 doi: 10.1016/j.intimp.2021.107398
|
| 24 |
Lorna Ewart, Athanasia Apostolou, Skyler A. Briggs, Christopher V. Carman, Jake T. Chaff, Anthony R. Heng, Sushma Jadalannagari, Jeshina Janardhanan, Kyung-Jin Jang, Sannidhi R. Joshipura, Mahika M. Kadam, Marianne Kanellias, Ville J. Kujala, Gauri Kulkarni, Christopher Y. Le, Carolina Lucchesi, Dimitris V. Manatakis, Kairav K. Maniar, Meaghan E. Quinn, Joseph S. Ravan, Ann Catherine Rizos, John F. K. Sauld, Josiah D. Sliz, William Tien-Street, Dennis Ramos Trinidad, James Velez, Max Wendell, Onyi Irrechukwu, Prathap Kumar Mahalingaiah, Donald E. Ingber, Jack W. Scannell, Daniel Levner. Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology. Communications Medicine 2022; 2(1) doi: 10.1038/s43856-022-00209-1
|
| 25 |
David E Amacher. The primary role of hepatic metabolism in idiosyncratic drug-induced liver injury. Expert Opinion on Drug Metabolism & Toxicology 2012; 8(3): 335 doi: 10.1517/17425255.2012.658041
|
| 26 |
Aditya K Gupta, Deanne Daigle, Kelly A Foley. Drug safety assessment of oral formulations of ketoconazole. Expert Opinion on Drug Safety 2015; 14(2): 325 doi: 10.1517/14740338.2015.983071
|
| 27 |
Ching-Yun Chen, Tsai-Shin Chiang, Ling-Ling Chiou, Hsuan-Shu Lee, Feng-Huei Lin. 3D cell clusters combined with a bioreactor system to enhance the drug metabolism activities of C3A hepatoma cell lines. Journal of Materials Chemistry B 2016; 4(43): 7000 doi: 10.1039/C6TB01627H
|
| 28 |
Raida Zouari, Rihab Ben Abdallah‐Kolsi, Khaled Hamden, Abdelfattah El Feki, Khansa Chaabouni, Fatma Makni‐Ayadi, Fahima Sallemi, Semia Ellouze‐Chaabouni, Dhouha Ghribi‐Aydi. Assessment of the antidiabetic and antilipidemic properties of bacillus subtilis spb1 biosurfactant in alloxan‐induced diabetic rats. Peptide Science 2015; 104(6): 764 doi: 10.1002/bip.22705
|
| 29 |
Yuping Wang, Tao Chen, Weida Tong. Mirnas and their Application in Drug-Induced Liver Injury. Biomarkers in Medicine 2014; 8(2): 161 doi: 10.2217/bmm.13.147
|
| 30 |
Yilong Teng, Haohui Liang, Zeng Zhang, Yanming He, Yanna Pan, Shilin Yuan, Xiao Wu, Qingjie Zhao, Hongjie Yang, Ping Zhou. Biodistribution and immunomodulatory activities of a proteoglycan isolated from Ganoderma lucidum. Journal of Functional Foods 2020; 74: 104193 doi: 10.1016/j.jff.2020.104193
|
| 31 |
María L. Ruiz, Aldo D. Mottino, Viviana A. Catania, Mary Vore. Comprehensive Physiology. 2013; : 1721 doi: 10.1002/cphy.c130018
|
| 32 |
Hamed Khalili, Barham Abu Dayyeh, Lawrence S. Friedman. Chronic Liver Failure. 2011; : 47 doi: 10.1007/978-1-60761-866-9_3
|
| 33 |
Khalid Alhazzani, Salah Q Alrewily, Khaldoon Aljerian, Khaled Alhosaini, Mohammad M. Algahtani, Mohammed Fhad Almutery, Abdullah S Alhamed, Ahmed Nadeem, Moureq R. Alotaibi, Ahmed Z. Alanazi. Hydroxychloroquine ameliorates dasatinib-induced liver injury via decrease in hepatic lymphocytes infiltration. Human & Experimental Toxicology 2023; 42 doi: 10.1177/09603271231188492
|
| 34 |
Arthur Shiyovich, Lior Nesher, Ignacio Sztarkier. Toxic Hepatitis Induced by Gymnema sylvestre, a Natural Remedy for Type 2 Diabetes Mellitus. The American Journal of the Medical Sciences 2010; 340(6): 514 doi: 10.1097/MAJ.0b013e3181f41168
|
| 35 |
Alireza Timcheh-Hariri, Mahdi Balali-Mood, Ehsan Aryan, Mahmood Sadeghi, Bamdad Riahi-Zanjani. Toxic hepatitis in a group of 20 male body-builders taking dietary supplements. Food and Chemical Toxicology 2012; 50(10): 3826 doi: 10.1016/j.fct.2012.07.006
|
| 36 |
Zhishen Jiang, Liu Liu, Hengpei Su, Yubin Cao, Zhongkai Ma, Yujie Gao, Dingming Huang. Curcumin and analogues in mitigating liver injury and disease consequences: From molecular mechanisms to clinical perspectives. Phytomedicine 2024; 123: 155234 doi: 10.1016/j.phymed.2023.155234
|
| 37 |
Katarzyna R Przybylak, Mark TD Cronin. In silicomodels for drug-induced liver injury – current status. Expert Opinion on Drug Metabolism & Toxicology 2012; 8(2): 201 doi: 10.1517/17425255.2012.648613
|
| 38 |
Dennie GA Hebels, Marlon JA Jetten, Hugo JW Aerts, Ralf Herwig, Daniël HJ Theunissen, Stan Gaj, Joost H van Delft, Jos CS Kleinjans. Evaluation of Database-Derived Pathway Development for Enabling Biomarker Discovery for Hepatotoxicity. Biomarkers in Medicine 2014; 8(2): 185 doi: 10.2217/bmm.13.154
|
| 39 |
Teresa Stelzer, Sibylle Kohler, Ewerton Marques Maggio, Ludwig Theodor Heuss. An unusual cause of febrile hepatitis. BMJ Case Reports 2015; : bcr2014205857 doi: 10.1136/bcr-2014-205857
|
| 40 |
Tsai-Shin Chiang, Kai-Chiang Yang, Yao-Ming Wu, Hong-Shiee Lai, Ching-Chuan Jiang, Ling-Ling Chiou, Kuang-Lun Lee, Guan-Tarn Huang, Hsuan-Shu Lee. Higher expression of cytochrome P450 3A4 in human mesenchymal and adipose-derived stem cells than in dermal fibroblasts: With emphasis on the correlation with basal pregnane X receptor expression. Process Biochemistry 2014; 49(11): 1983 doi: 10.1016/j.procbio.2014.08.006
|
| 41 |
Selvaraj Kunjiappan, Chiranjib Bhattacharjee, Ranjana Chowdhury. In vitro antioxidant and hepatoprotective potential of Azolla microphylla phytochemically synthesized gold nanoparticles on acetaminophen – induced hepatocyte damage in Cyprinus carpio L.. In Vitro Cellular & Developmental Biology - Animal 2015; 51(6): 630 doi: 10.1007/s11626-014-9841-3
|
| 42 |
Kaarina Kowalec, Elaine Kingwell, Eric M Yoshida, Ruth Ann Marrie, Marcelo Kremenchutzky, Trudy L Campbell, Mia Wadelius, Bruce Carleton, Helen Tremlett. Characteristics associated with drug-induced liver injury from interferon beta in multiple sclerosis patients. Expert Opinion on Drug Safety 2014; 13(10): 1305 doi: 10.1517/14740338.2014.947958
|
| 43 |
Qiang Shi, Huixiao Hong, John Senior, Weida Tong. Biomarkers for drug-induced liver injury. Expert Review of Gastroenterology & Hepatology 2010; 4(2): 225 doi: 10.1586/egh.10.8
|
| 44 |
Ioannis Kyriakidis, Athanasios Tragiannidis, Silke Munchen, Andreas H. Groll. Clinical hepatotoxicity associated with antifungal agents. Expert Opinion on Drug Safety 2016; : 1 doi: 10.1080/14740338.2017.1270264
|
| 45 |
Farzin Firouzian, Parisa Pourshoja, Amir Nili-Ahmadabadi, Akram Ranjbar. Hepatoprotective effect of N-acetylcystein loaded niosomes on liver function in paraquat-induced acute poisoning. Pesticide Biochemistry and Physiology 2019; 160: 146 doi: 10.1016/j.pestbp.2019.08.001
|
| 46 |
Yu Wu, Xing-chao Geng, Ju-feng Wang, Yu-fa Miao, Yan-li Lu, Bo Li. The HepaRG cell line, a superior in vitro model to L-02, HepG2 and hiHeps cell lines for assessing drug-induced liver injury. Cell Biology and Toxicology 2016; 32(1): 37 doi: 10.1007/s10565-016-9316-2
|
| 47 |
Qiang Su, Qiao Liu, Juan Liu, Lingyun Fu, Tao Liu, Jing Liang, Hong Peng, Xue Pan. Study on the associations between liver damage and antituberculosis drug rifampicin and relative metabolic enzyme gene polymorphisms. Bioengineered 2021; 12(2): 11700 doi: 10.1080/21655979.2021.2003930
|
| 48 |
Yi Jin, Yanjie Tan, Pengxiang Zhao, Yu Guo, Shilin Chen, Jian Wu, Zhuqing Ren. Glutathione S-transferase Mu 2 inhibits hepatic steatosis via ASK1 suppression. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-03251-w
|
| 49 |
Alejandra Cano Paniagua, Pedro Amariles. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. 2018; doi: 10.5772/intechopen.72005
|
| 50 |
Narmin Mokarizadeh, Pouran Karimi, Hamid Kazemzadeh, Nazila Fathi Maroufi, Saeed Sadigh-Eteghad, Saba Nikanfar, Nadereh Rashtchizadeh. An evaluation on potential anti-inflammatory effects of β-lapachone. International Immunopharmacology 2020; 87: 106810 doi: 10.1016/j.intimp.2020.106810
|
| 51 |
Milos Mihajlovic, Mathieu Vinken. Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods. International Journal of Molecular Sciences 2022; 23(6): 3315 doi: 10.3390/ijms23063315
|
| 52 |
Rolf Teschke. Treatment of Drug-Induced Liver Injury. Biomedicines 2022; 11(1): 15 doi: 10.3390/biomedicines11010015
|
| 53 |
Yoo-Sub Shin, Da-Bin Hwang, Dong-Hoon Won, Shin-Young Kim, Changuk Kim, Jun Won Park, Young Jeon, Jun-Won Yun. The Wnt/β-catenin signaling pathway plays a role in drug-induced liver injury by regulating cytochrome P450 2E1 expression. Toxicological Research 2023; 39(3): 443 doi: 10.1007/s43188-023-00180-6
|
| 54 |
Debasis Sahu, Subasa Chandra Bishwal, Md. Zubbair Malik, Sukanya Sahu, Sandeep Rai Kaushik, Shikha Sharma, Ekta Saini, Rakesh Arya, Archana Rastogi, Sandeep Sharma, Shanta Sen, R. K. Brojen Singh, Chuan-Ju Liu, Ranjan Kumar Nanda, Amulya Kumar Panda. Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.845457
|
| 55 |
Qingmei Ma, Wenjuan Yang, Lu Wang, Li Ma, Yanmei Jing, Jiamei Wang, Xinyue Liu. Research advances in the association of drug-induced liver injury with polymorphisms in human leukocyte antigen. International Immunopharmacology 2020; 81: 106037 doi: 10.1016/j.intimp.2019.106037
|
| 56 |
Tsai-Shin Chiang, Kai-Chiang Yang, Ling-Ling Chiou, Guan-Tarn Huang, Hsuan-Shu Lee, Edward E. Schmidt. Enhancement of CYP3A4 Activity in Hep G2 Cells by Lentiviral Transfection of Hepatocyte Nuclear Factor-1 Alpha. PLoS ONE 2014; 9(4): e94885 doi: 10.1371/journal.pone.0094885
|
| 57 |
Yuting Qiu, Dandan Ning, Peipei Zhang, Stephanie Curly, Yong Qiao, Liyuan Ma, Ming Su. Three-dimensional microtissues as an in vitro model for personalized radiation therapy. The Analyst 2017; 142(19): 3605 doi: 10.1039/C7AN00794A
|
| 58 |
Constantine E. Kosmas, Hassan Alkhawam, Mohammed El-Hunjul, Gabriel Wagman, Timothy J. Vittorio, Mark R. Kahn, Kathleen M. Grady. Statin-Mediated Low-Density Lipoprotein Lowering in Chronic Congestive Heart Failure. The American Journal of the Medical Sciences 2014; 347(1): 14 doi: 10.1097/MAJ.0b013e318273514c
|
| 59 |
Justin Mandala, Kavita Nanda, Meng Wang, Irith De Baetselier, Jennifer Deese, Johan Lombaard, Fredrick Owino, Mookho Malahleha, Rachel Manongi, Douglas Taylor, Lut Van Damme. Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial. BMC Pharmacology and Toxicology 2014; 15(1) doi: 10.1186/2050-6511-15-77
|
| 60 |
Saeed Mohammed Imran Hosen, Dipesh Das, Rupkanowar Kobi, Dil Umme Salma Chowdhury, Md Jibran Alam, Bashudev Rudra, Muhammad Abu Bakar, Saiful Islam, Zillur Rahman, Mohammad Al-Forkan. Study of arsenic accumulation in rice and evaluation of protective effects of Chorchorus olitorius leaves against arsenic contaminated rice induced toxicities in Wistar albino rats. BMC Pharmacology and Toxicology 2016; 17(1) doi: 10.1186/s40360-016-0091-8
|
| 61 |
|
| 62 |
Amit Datta, Md. Jibran Alam, Laila Khaleda, Mohammad Al-Forkan. Protective effects of Corchorus olitorius and Butea monosperma against Arsenic induced aberrant methylation and mitochondrial DNA damage in wistar rat model. Toxicology Reports 2021; 8: 30 doi: 10.1016/j.toxrep.2020.12.017
|
| 63 |
Chenxia Hao, Xiaoqin Ma, Lining Wang, Weixia Zhang, Jiong Hu, Jingjing Huang, Wanhua Yang. Predicting the presence and mechanism of busulfan drug-drug interactions in hematopoietic stem cell transplantation using pharmacokinetic interaction network–based molecular structure similarity and network pharmacology. European Journal of Clinical Pharmacology 2021; 77(4): 595 doi: 10.1007/s00228-020-03034-4
|
| 64 |
Shuo Wang, Qi-Wen Han, Tian-Tian Zhou, Cheng-Lu Zhang, Cheng-gen Zhu, Xin Zhou, Nai-Hong Chen, Yu-He Yuan, Jian-Gong Shi. A bibenzyl compound 20C protects rats against 6-OHDA-induced damage by regulating adaptive immunity associated molecules. International Immunopharmacology 2021; 91: 107269 doi: 10.1016/j.intimp.2020.107269
|
| 65 |
Rolf Teschke. Molecular Idiosyncratic Toxicology of Drugs in the Human Liver Compared with Animals: Basic Considerations. International Journal of Molecular Sciences 2023; 24(7): 6663 doi: 10.3390/ijms24076663
|
| 66 |
Lin Wang, Shuyan Li, Xiaozhou Xu, Xiaoyan Xu, Qing Wang, Duanxiu Li, Hailu Zhang. Drug-drug cocrystals of theophylline with quercetin. Journal of Drug Delivery Science and Technology 2022; 70: 103228 doi: 10.1016/j.jddst.2022.103228
|
| 67 |
Matthew D. Merrell, Nathan J. Cherrington. Drug metabolism alterations in nonalcoholic fatty liver disease. Drug Metabolism Reviews 2011; 43(3): 317 doi: 10.3109/03602532.2011.577781
|
| 68 |
Amany Abdin, Naglaa Sarhan. Resveratrol protects against experimental induced Reye’s syndrome by prohibition of oxidative stress and restoration of complex I activity. Canadian Journal of Physiology and Pharmacology 2014; 92(9): 780 doi: 10.1139/cjpp-2014-0251
|
| 69 |
Yin Wu, Chao Hao, Xiongfei Liu, Guangye Han, Jun Yin, Zhongtao Zou, Jinfeng Zhou, Changzheng Xu. MitoQ protects against liver injury induced by severe burn plus delayed resuscitation by suppressing the mtDNA-NLRP3 axis. International Immunopharmacology 2020; 80: 106189 doi: 10.1016/j.intimp.2020.106189
|
| 70 |
Giacomo Casalini, Andrea Giacomelli, Spinello Antinori. Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review. Expert Opinion on Drug Safety 2022; 21(12): 1483 doi: 10.1080/14740338.2022.2160446
|
| 71 |
Tsai-Shin Chiang, Kai-Chiang Yang, Shu-Kai Zheng, Ling-Ling Chiou, Wen-Ming Hsu, Feng-Huei Lin, Guan-Tarn Huang, Hsuan-Shu Lee. The prediction of drug metabolism using scaffold-mediated enhancement of the induced cytochrome P450 activities in fibroblasts by hepatic transcriptional regulators. Biomaterials 2012; 33(21): 5187 doi: 10.1016/j.biomaterials.2012.04.014
|
| 72 |
Qi Yin, Xuelei Pi, Guiping Ren, Zhihang Liu, Han Liu, Mengxia Wang, Changhui Hu, Han Zhao, Deshan Li, Jiechao Yin. A novel bispecific antibody alleviates bleomycin-induced systemic sclerosis injury. International Immunopharmacology 2020; 85: 106644 doi: 10.1016/j.intimp.2020.106644
|
| 73 |
James RM Black, Robert D Goldin, Matthew Foxton, Teresa Marafioti, Ayse U Akarca, Alessia Dalla Pria, Cathryn Brock, Mark Bower, David J Pinato. PD-L1 Expressing Granulomatous Reaction As An On-Target Mechanism of Steroid-Refractory Immune Hepatotoxicity. Immunotherapy 2019; 11(7): 585 doi: 10.2217/imt-2018-0187
|
| 74 |
Yongxiang Xie, Fang Lan, Jie Zhao, Wei Shi. Hirudin improves renal interstitial fibrosis by reducing renal tubule injury and inflammation in unilateral ureteral obstruction (UUO) mice. International Immunopharmacology 2020; 81: 106249 doi: 10.1016/j.intimp.2020.106249
|
| 75 |
Jagjeet Singh, Annu Phogat, Chandra Prakash, Sunil Kumar Chhikara, Sandeep Singh, Vinay Malik, Vijay Kumar. N-Acetylcysteine Reverses Monocrotophos Exposure-Induced Hepatic Oxidative Damage via Mitigating Apoptosis, Inflammation and Structural Changes in Rats. Antioxidants 2021; 11(1): 90 doi: 10.3390/antiox11010090
|
| 76 |
Roderick Clark, Judith E Fisher, Ingrid S Sketris, Grace M Johnston. Population prevalence of high dose paracetamol in dispensed paracetamol/opioid prescription combinations: an observational study. BMC Clinical Pharmacology 2012; 12(1) doi: 10.1186/1472-6904-12-11
|
| 77 |
Rolf Teschke. Alcoholic steatohepatitis (ASH) and alcoholic hepatitis (AH): cascade of events, clinical aspects, and pharmacotherapy options. Expert Opinion on Pharmacotherapy 2018; 19(8): 779 doi: 10.1080/14656566.2018.1465929
|
| 78 |
Pedro Gaspar-da-Costa, Filipa Duarte Silva, Júlia Henriques, Sónia do Vale, Sandra Braz, João Meneses Santos, Rui M.M. Victorino. Methimazole associated eosinophilic pleural effusion: a case report. BMC Pharmacology and Toxicology 2017; 18(1) doi: 10.1186/s40360-017-0121-1
|
| 79 |
Qiang Shi, Xi Yang, Donna L Mendrick. Hopes and Challenges in using miRNAs as Translational Biomarkers for Drug-Induced Liver Injury. Biomarkers in Medicine 2013; 7(2): 307 doi: 10.2217/bmm.13.9
|
| 80 |
Matteo Bassetti, Antonio Vena, Daniele Roberto Giacobbe. The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections. Expert Opinion on Drug Safety 2023; 22(7): 533 doi: 10.1080/14740338.2023.2227085
|
| 81 |
H. Karl Greenblatt, David J. Greenblatt. Liver injury associated with ketoconazole: Review of the published evidence. The Journal of Clinical Pharmacology 2014; 54(12): 1321 doi: 10.1002/jcph.400
|
| 82 |
Lei Zheng, Hao-bin Jin, Yu-yao Guan, Jing Yang. Pharmacovigilance of cutaneous adverse drug reactions in associations with drugs and medical conditions: a retrospective study of hospitalized patients. BMC Pharmacology and Toxicology 2022; 23(1) doi: 10.1186/s40360-022-00603-4
|
| 83 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2010; 19(1) doi: 10.1002/pds.1846
|
| 84 |
|
| 85 |
Xu Yang, Nan Li, Tingting Guo, Xiaoyuan Guan, Jiangshan Tan, Xin Gao, Yan Wu, Lei Jia, Min Gu, Lu Hua, Hong Liu. Comparison of the Effects of Low‐Molecular‐Weight Heparin and Fondaparinux on Liver Function in Patients With Pulmonary Embolism. The Journal of Clinical Pharmacology 2020; 60(12): 1671 doi: 10.1002/jcph.1686
|
| 86 |
Feroz Ahmad, Nahida Tabassum. Experimental models used for the study of antihepatotoxic agents. Journal of Acute Disease 2012; 1(2): 85 doi: 10.1016/S2221-6189(13)60021-9
|
| 87 |
Ziying Xu, Qianjun Kang, Zihui Yu, Lichun Tian, Jingxuan Zhang, Ting Wang. Research on the Species Difference of the Hepatotoxicity of Medicine Based on Transcriptome. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.647084
|
| 88 |
Chunhua Wang, Qimeng Tao, Xinghe Wang, Xiurong Wang, Xiuying Zhang. Impact of high-fat diet on liver genes expression profiles in mice model of nonalcoholic fatty liver disease. Environmental Toxicology and Pharmacology 2016; 45: 52 doi: 10.1016/j.etap.2016.05.014
|
| 89 |
Hai Zou, Lie Jin, Li-Ren Wang, Martin Braddock, Wen-Wei Cai, Ming-Hua Zheng. Methimazole-induced cholestatic hepatitis: two cases report and literature review. Oncotarget 2016; 7(4): 5088 doi: 10.18632/oncotarget.6144
|
| 90 |
Raúl J Andrade, Mercedes Robles, María Isabel Lucena. Rechallenge in drug-induced liver injury: the attractive hazard. Expert Opinion on Drug Safety 2009; 8(6): 709 doi: 10.1517/14740330903397378
|
| 91 |
Chung-Hsiung Huang, Chia-Chi Wang, Yu-Chin Lin, Masatoshi Hori, Tong-Rong Jan. Oral administration with diosgenin enhances the induction of intestinal T helper 1-like regulatory T cells in a murine model of food allergy. International Immunopharmacology 2017; 42: 59 doi: 10.1016/j.intimp.2016.11.021
|
| 92 |
Yawo M Akrodou. NRCT Clinical Study in to Acetaminophen-Induced Liver Injury. MOJ Public Health 2016; 4(2) doi: 10.15406/mojph.2016.04.00072
|
| 93 |
Raida Zouari, Khaled Hamden, Abdelfattah El Feki, Khansa Chaabouni, Fatma Makni-Ayadi, Fahima Sallemi, Semia Ellouze-Chaabouni, Dhouha Ghribi-Aydi. Evaluation ofBacillus subtilisSPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat–high-fructose diet. Archives of Physiology and Biochemistry 2017; 123(2): 112 doi: 10.1080/13813455.2016.1261902
|
| 94 |
Bola Tayo, Lesley Taylor, Farhad Sahebkar, Gilmour Morrison. A Phase I, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics, Safety, and Tolerability of Cannabidiol in Subjects with Mild to Severe Renal Impairment. Clinical Pharmacokinetics 2020; 59(6): 747 doi: 10.1007/s40262-019-00841-6
|
| 95 |
Vanessa Alves-Conceição, Daniel Tenório da Silva, Vanessa Lima de Santana, Edileide Guimarães dos Santos, Lincoln Marques Cavalcante Santos, Divaldo Pereira de Lyra. Evaluation of pharmacotherapy complexity in residents of long-term care facilities: a cross-sectional descriptive study. BMC Pharmacology and Toxicology 2017; 18(1) doi: 10.1186/s40360-017-0164-3
|
| 96 |
Huiqun Dong, Jia You, Yu Zhao, Danhua Zheng, Yi Zhong, Gaozheng Li, Zuquan Weng, Heng Luo, Shan Jiang. Study on the Characteristics of Small-Molecule Kinase Inhibitors-Related Drug-Induced Liver Injury. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.838397
|
| 97 |
Junming Wang, Mingsan Miao, Yueyue Zhang, Ruixin Liu, Xaobing Li, Ying Cui, Lingbo Qu. Quercetin ameliorates liver injury induced with Tripterygium glycosides by reducing oxidative stress and inflammation. Canadian Journal of Physiology and Pharmacology 2015; 93(6): 427 doi: 10.1139/cjpp-2015-0038
|
| 98 |
Liliam Pineda Salgado, Ritu Gupta, Michael Jan, Osman Turkoglu, Alvin Estilo, Vinu George, Mirza I. Rahman. Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database. Advances in Therapy 2021; 38(9): 4709 doi: 10.1007/s12325-021-01856-x
|
| 99 |
O. KUČERA, H. LOTKOVÁ, O. SOBOTKA, Z. ČERVINKOVÁ. The Effect of D-Galactosamine on Lean and Steatotic Rat Hepatocytes in Primary Culture. Physiological Research 2015; : S637 doi: 10.33549/physiolres.933225
|
| 100 |
Haritha Polimati, Rajeswara Rao Pragada, Nguyen Huy Thuan, Vinay Bharadwaj Tatipamula. . Studies in Natural Products Chemistry 2022; 72: 259 doi: 10.1016/B978-0-12-823944-5.00014-4
|
| 101 |
Lesley Taylor, Julie Crockett, Bola Tayo, Gilmour Morrison. A Phase 1, Open‐Label, Parallel‐Group, Single‐Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment. The Journal of Clinical Pharmacology 2019; 59(8): 1110 doi: 10.1002/jcph.1412
|
| 102 |
Yuhong Li, Qi Ren, Lingyan Zhu, Yingshu Li, Jinfeng Li, Yiyang Zhang, Guoying Zheng, Tiesheng Han, Shufeng Sun, Fumin Feng. Involvement of methylation of MicroRNA-122, −125b and -106b in regulation of Cyclin G1, CAT-1 and STAT3 target genes in isoniazid-induced liver injury. BMC Pharmacology and Toxicology 2018; 19(1) doi: 10.1186/s40360-018-0201-x
|
| 103 |
Seval TÜRK, Alexandra CERNOMORCENCO, Esma KIRIMLIOĞLU. Effect on Endoplasmic Reticulum Stress of the Combined Oral Contraceptives in the Liver. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi 2024; 10(1): 1 doi: 10.30934/kusbed.1281214
|